Medicine and Dentistry
Interstitial Lung Disease
100%
Idiopathic Pulmonary Fibrosis
87%
Diagnosis
75%
Lung Cancer
73%
Disease
69%
Symptom
43%
Chronic Obstructive Pulmonary Disease
40%
Acoustic Rhinometry
27%
Lung Biopsy
25%
Computer Assisted Tomography
25%
Dyspnea
24%
Silo-Filler's Disease
24%
Cohort Analysis
23%
Asthma
22%
Randomized Controlled Trial
19%
COVID-19
18%
Severe Asthma
18%
Quality of Life
18%
Nasal Cavity
16%
Symptomatic Treatment
16%
Sarcoidosis
16%
Idiopathic Interstitial Pneumonia
15%
Forced Vital Capacity
15%
Biopsy
15%
Malignant Neoplasm
14%
Non Small Cell Lung Cancer
14%
Lung Nodule
14%
Interstitial Lung Disorder
13%
Rheumatoid Arthritis
12%
Systematic Review
12%
Lung Transplantation
12%
High-Resolution Computed Tomography
12%
Prevalence
12%
Pulmonary Fibrosis
12%
Infection
11%
Biological Marker
11%
Pirfenidone
11%
Observational Study
10%
Biological Product
10%
Clinician
10%
Pneumothorax
10%
Immunotherapy
9%
Cancer Registry
9%
Usual Interstitial Pneumonia
9%
Diagnostic Accuracy
9%
Drug Therapy
9%
Positron Emission Tomography-Computed Tomography
8%
Disease Course
8%
Atypical Mycobacterium
8%
Patient Referral
8%
Low Drug Dose
8%
Disease Exacerbation
8%
Rehabilitation Engineering
8%
Allergen
7%
Coughing
7%
Hypersensitivity Pneumonitis
7%
Cancer Diagnosis
7%
Fibrosis
7%
Mediastinal Lymph Node
7%
Retrospective Cohort Study
7%
Respiratory Failure
7%
Nasal Congestion
7%
Obstructive Sleep Apnea
7%
Lung
7%
Telerehabilitation
7%
Placebo
6%
Lung Lavage
6%
Endobronchial Ultrasonography
6%
General Medicine
6%
Lung Function
6%
Pulmonary Hypertension
6%
Exercise
6%
Six Minute Walk Test
6%
Emergency Department
6%
Hazard Ratio
6%
Patient-Reported Outcome
6%
Primary Health Care
6%
Lung Infection
6%
Nintedanib
6%
Radiation Therapy
6%
Smoking
6%
General Practitioner
6%
Pathophysiology
5%
Thoracentesis
5%
Odds Ratio
5%
Echography
5%
Histopathology
5%
Volume CT
5%
Spirometry
5%
Mycobacterium Avium-Intracellulare Infection
5%
Lower Respiratory Tract Infection
5%
Mortality Rate
5%
Interferon Gamma Release Assay
5%
Advance Care Planning
5%
Hemidiaphragm
5%
Cross Sectional Study
5%
Lymph Node
5%
All Cause Mortality
5%
Postcovid Syndrome
5%
Diseases
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosing Alveolitis
55%
Lung Cancer
53%
Chronic Obstructive Lung Disease
45%
Interstitial Lung Disease
45%
Asthma
36%
Disease
36%
Cohort Study
23%
Symptom
23%
Randomized Controlled Trial
18%
Nintedanib
16%
Placebo
16%
Comorbidity
15%
Lung Disease
15%
Prevalence
14%
Biological Marker
13%
Biological Product
11%
Non Small Cell Lung Cancer
11%
Infection
9%
Pirfenidone
9%
Adverse Event
9%
Interstitial Pneumonia
9%
Neoplasm
8%
Inflammation
8%
Malignant Neoplasm
7%
Disease Exacerbation
7%
Observational Study
7%
Pulmonary Hypertension
7%
Atypical Mycobacterium
7%
Lung Nodule
7%
Dyspnea
6%
Allergen
6%
All Cause Mortality
6%
Remission
6%
Clinical Trial
6%
Lung Fibrosis
6%
Coronavirinae
5%
Respiratory Tract Disease
5%
Lung Infection
5%
Tuberculosis
5%
Indacaterol
5%
Allergic Pneumonitis
5%
Immunoglobulin E
5%
Disease Severity
5%
Fibrosis
5%
Immunology and Microbiology
Allergen
32%
Asthma
28%
Immunotherapy
23%
Mast Cell
21%
Severe Asthma
21%
Immunoglobulin E
18%
Comorbidity
16%
Prevalence
14%
Allergic Pneumonitis
12%
Forced Vital Capacity
10%
Allergic Rhinitis
9%
Basophil Granulocyte
9%
Inflammatory Arthritis
9%
Nontuberculous mycobacteria
9%
Biological Product
8%
Lung Function
8%
Allergen Immunotherapy
7%
Basophil Activation
6%
Inflammatory Bowel Disease
6%
Basophil
6%
Grass Pollen
6%
Computer Assisted Tomography
6%
Respiratory Tract Allergy
5%
Crohn's Disease
5%
Systemic Scleroderma
5%
Surface Property
5%
Breathing
5%
Nintedanib
5%